EVER Pharma - Product List

EVER Pharma is pleased to announce EU-wide approval of Bortezomib for the treatment of patients with multiple myeloma and mantle cell lymphoma

EVER Pharma offers a wide range of services which includes clinical and commercial supply services. 
It offers a high level of expertise to support the manufacturing of clinical products from phase I to phase III; prepare and complete PPQ manufacturing and support commercial product for worldwide markets. 

We are specialized in the manufacture of complex, injectable substances with a special focus on:
Handling of highly active substances (e.g. narcotics, hormones, cytotoxics)Low-oxygen formulationsCrystal suspensionsOily solutionsWe also offer our customers support for development, regulation, production, and testing:

Validation, analytical services, and clinical batch manufacturingCommercial manufacture of sterile dosage formsSecondary packaging and storageOptimization of formulations and processesAnalytical testing of sterile dosage formsStability testTechnical advice
Contact us for more information.

EVER Pharma's products include: Atosiban --  7.5 mg/ml Solution for Injection/InfusionAzacitidine -- 25 mg/ml Powder for Suspension for InjectionCabazitaxel -- 10 mg/ml - Solution for InfusionCerebrolysin® -- 215.2 mg/ml - Solution for Infusion Concentrate for Solution for InfusionDacepton (Apomorphine) -- 5 mg/ml & 10 mg/ml -  Solution for Injection/InfusionDexmedetomidine -- 100 µg/ml - Concentrate for Solution for InfusionDocetaxel -- 20 mg/ml - Concentrate for injectionFulvestrant -- 50 mg/ml - Ready to use pre-filled syringeOxytocin -- 5 IU/ml & 10 IU/ml - Solution for Injection/InfusionPaclitaxel-- 6 mg/ml - Concentrate for InjectionPemetrexed -- 25 mg/ml - Concentrate for Solution for InfusionTerlipressin -- 0.17 mg/ml - Solution for Injection/Infusion

Overview on CMO services offered by EVER Pharma

45mg/4.5ml + 50mg/5.0ml + 60mg/6ml